Joint profiling of gene expression and chromatin accessibility in pancreatic lymph nodes and spleens in human type 1 diabetes

Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing β cells in the pancreas. While current therapies focus on managing the disease, a deeper understanding of the underlying molecular mechanisms is crucial for developing disease-modifying interventions. In this study, we conducted a comprehensive analysis of gene expression and chromatin accessibility in nearly 1 million immune cells from the pancreatic lymph nodes and spleens of 43 individuals with and without T1D. We found a distinct subset of CD4 T cells specifically present in the pancreatic lymph nodes of organ donors representing the active disease stage. These cells exhibited elevated activity of <i>NFKB1</i> and <i>BACH2</i>, along with extensive chromatin remodeling associated with these transcription factors, which we also corroborated in a mouse model of T1D. A better understanding of these <i>NFKB1-BACH2</i>-expressing CD4 T cells may lead to therapeutic avenues for preventing or delaying T1D onset.

Authors

Institutions

Publication Details

Journal
Science Immunology
Published
2025-11-21
DOI
https://doi.org/10.1126/sciimmunol.adz0472
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Joint profiling of gene expression and chromatin accessibility in pancreatic lymph nodes and spleens in human type 1 diabetes

Golnaz Vahedi, Klaus H. Kaestner, Isabelle Johnson, Aditi Chandra et al.
Science Immunology
Diabetes and associated disorders
article

Joint profiling of gene expression and chromatin accessibility in pancreatic lymph nodes and spleens in human type 1 diabetes

Golnaz Vahedi, Klaus H. Kaestner, Isabelle Johnson, Aditi Chandra, Maria Fasolino, Robert B. Faryabi, Priyadarshini Rai, Atishay Jay, Vung Lian, Michael A. Silverman, Yeqiao Zhou, Susan Rostami, Yanjing Li, Ali Naji, Wei Wang, Chengyang Liu, Ming Yu, Maryam Abedi, Z. Min
article en

Abstract

Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing β cells in the pancreas. While current therapies focus on managing the disease, a deeper understanding of the underlying molecular mechanisms is crucial for developing disease-modifying interventions. In this study, we conducted a comprehensive analysis of gene expression and chromatin accessibility in nearly 1 million immune cells from the pancreatic lymph nodes and spleens of 43 individuals with and without T1D. We found a distinct subset of CD4 T cells specifically present in the pancreatic lymph nodes of organ donors representing the active disease stage. These cells exhibited elevated activity of <i>NFKB1</i> and <i>BACH2</i>, along with extensive chromatin remodeling associated with these transcription factors, which we also corroborated in a mouse model of T1D. A better understanding of these <i>NFKB1-BACH2</i>-expressing CD4 T cells may lead to therapeutic avenues for preventing or delaying T1D onset.

Science ImmunologyVol. 10(113)
Children's Hospital of Philadelphia (US), University of Pennsylvania (US)
Openalex Percentile: Top 62%
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.